Navigation Links
Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
Date:1/6/2011

astrointestinal-derived peptide hormones that have been associated with producing satiety and reducing food intake.  PYY has been studied as an anti-obesity agent, and GLP-1 is a mediator of insulin and glucagon secretion.  As nutrients enter the small intestine, PYY and GLP-1 are co-secreted into the circulation by neuroendocrine cells (L cells) of the gastrointestinal tract.

"We have established a solid tablet formulation suitable for further development and will continue to explore LX4211's unique mechanism of action in the treatment of diabetes and the hormonal control of metabolism," said Arthur T. Sands, M.D., Ph.D., president and chief executive officer. "We believe the results of this study provide further evidence that dual inhibition of SGLT1 and SGLT2 may provide enhanced glycemic control over SGLT2 inhibition alone, consistent with the remarkable results observed in our Phase 2a clinical trial of LX4211."

About the Clinical Trial

The clinical trial compared a new solid oral dose formulation of LX4211 to the liquid dose formulation used in prior clinical trials of LX4211.  The trial employed a randomized, triple-cross over design during which 12 patients with type 2 diabetes each received 300 mg of LX4211 in different dose forms.  Patients were administered a single dose of two 150 mg tablets, six 50 mg tablets or a 300 mg liquid dose formulation in varying sequences at 5-day intervals over a total period of 15 days.  Pharmacokinetic and pharmacodynamic measures were monitored at frequent time points at baseline and after administration of each of the three dose forms with baseline measures prior to dosing used as controls.

Additional details regarding the results from this latest clinical study will be presented on Monday, January 10, 2011 at the JP Morgan Healthcare Conference.  A live webcast of the presentation will be available
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
2. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
3. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
4. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
5. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
6. Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
7. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
8. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
9. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
10. Lexicon to Present at BIO International Convention
11. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Calif. , March 2, 2015 Isis Pharmaceuticals, ... has earned a $15 million milestone payment from GSK related ... in patients with familial amyloid polyneuropathy (FAP).  ... with ISIS-TTR Rx , and plan to report data from ... have completed the fifteen months of dosing and are now ...
(Date:3/2/2015)... BETHESDA, Md. , March 2, 2015 ... on treating and preventing autoimmune diseases, announced today that ... (AMG 714) from Amgen (NASDAQ: AMGN ). ... has the rights to develop, manufacture and commercialize AMG ... . Concurrently, Amgen has been granted an exclusive ...
(Date:3/2/2015)... Texas , March 2, 2015   Lexicon ... biopharmaceutical company focused on developing breakthrough treatments for human ... 2014 financial results on Wednesday, March 4, 2015 before ... conference call and webcast to discuss clinical development progress ... end of 2014 at 10:00 a.m. Eastern Time on ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 2Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... plc (Nasdaq: JAZZ ) today announced several ... company,s leadership team. The appointments include: ... company and will serve as general counsel and an ... in March.  Ms. Hooper is currently a partner at ...
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... a letter dated January 18, 2012 from The Nasdaq Stock ... from the Company,s Board of Directors effective January 4, 2012, ... Nasdaq,s requirement that its audit committee consists of at least ...
Cached Medicine Technology:Jazz Pharmaceuticals plc Announces New Executive Appointments 2Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement 2
(Date:3/2/2015)... California (PRWEB) March 02, 2015 Final ... of the TranStatic Volume 2 from Pixel Film Studios. , ... made exclusively for FCPX,” said Christina Austin, CEO of Pixel ... have in any Final Cut Pro X editors toolbox.” , ... to the next with media altering static scrambling effects from ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce ... on their website. There are over 75 terms and phrases ... , “This gives our patients a better understanding of what ... they may not understand. With this resource, our patients are ... and find terms and phrases that they may not remember or ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
(Date:3/1/2015)... “ The Barrel Mill ” was featured ... takes a look at the latest and coolest technology products ... NewsWatch and a technology expert, conducted the review and shared ... drinks. , According to Home Distillation of Alcohol, it's understood ... there’s a pretty cool product that’ll help anyone achieve a ...
(Date:2/28/2015)... Heart diseases are on the rise in India. ... population and 5 percent of rural adult population suffer ... of them require specialized investigation and treatment to prevent ... (CVD). , A division of Indian Business News Agency ... “Indian Coronary Stent Market Forecast to 2019”. The new ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... ... weight loss can be with HCG Diet Drops , ... (PRWEB) June 14, 2010 -- It is no secret that obesity has reached epidemic ... suffering from health problems as a result of the extra pounds. , , ,But thanks ...
... CerMedia ... the Cell-Pore product group previously owned and operated by NanoDynamics, Inc. ... Buffalo, NY (PRWEB) ... of the principal manufacturing and production assets, inventory and certain information of the Cell-Pore ...
... ... specialist in cosmetic, facial plastic, and reconstructive surgery, understands that women need options. With ... patients an alternative method to breast implant surgery. Natural breast augmentation allows patients the ... ...
... N.C. Monday, June 14, 2010 A new study ... shows that millions of cancer survivors are forgoing needed medical ... today in CANCER, a peer-reviewed journal of the ... long-term health and well-being of cancer survivors could suffer because ...
... ... medical and financial benefits. The Sit&SipTM bottle is engineered for easy and healthy performance. ... ... 15 - 20 million visits to the doctor each year in the U.S. Acute ...
... ... , ... The Primax Electronic Cigarette System is now available from Primevapor.com., , ,Primevapor has combined a ... These cartridges not only produce more flavor and more vapor, but use US manufactured, vegetable ...
Cached Medicine News:Health News:Thousands Drop The Weight For Good with HCG Diet Drops 2Health News:CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics 2Health News:Del Mar Plastic Surgeon Dr. Maurice Sherman Now Offering Natural Breast Implant Alternatives 2Health News:Cost concerns prevent many cancer survivors from getting medical care 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 2Health News:Ear Infection is the Most Common Reason Why an American Child Sees the Doctor 3Health News:Electronic Cigarettes Are Better Than Ever 2
The VPAP III is a complete system solution for sleep-disordered breathing (SDB), providing comfortable and effective bilevel treatment. The VPAP III is an effective business solution for clinicians, ...
... for the Separation and Measurement of ... Subfractions, ,The Lipoprint System is a ... components which are not routinely tested ... provides detailed results within the subfractions ...
... high resolution diagnostic test for cholesterol components which ... test procedure is simple and can be done ... is clearly flagged. A color coded profile is ... in red and the good HDL in green. ...
... Ammonia/Alcohol Control is intended as ... ammonia and ethanol assay methods. ... targeted at clinically significant levels ... values are provided for the ...
Medicine Products: